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MICAbstract In the present study, we have synthesized some novel 4-(4-(2-isonicotinoylhydrazinyl)-6-
((aryl)amino)-1,3,5-triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide derivatives (3a–v) and
evaluated their in vitro antimicrobial activity against the representative panel of Gram-positive bacte-
ria [Staphylococcus aureus (MTCC 96), Staphylococcus pyogenes (MTCC 442)], Gram-negative bac-
teria [Escherichia coli (MTCC 443), Pseudomonas aeruginosa (MTCC 1688)] and fungal strains
[Candida albicans (MTCC 227), Aspergillus niger (MTCC 282), Aspergillus clavatus (MTCC 1323)].
Evaluation of antimicrobial activity revealed that compounds 3g, 3h, 3t, and 3v were the most active
antibacterial, while compounds 3g, and 3h were the most potent antifungal agents. The structures of
synthesized compounds (3a–v) were elucidated by IR, NMR spectroscopy and elemental analysis.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
After years of misuse and overuse of antibiotics, bacteria are
becoming antibiotic resistant, therefore recent efforts havebeen directed toward exploring novel antibacterial agents
[16]. In order to overcome this rapid development of drug
resistance, new agents should preferably consist of chemical
characteristics that clearly differ from those of existing
agents. Nowadays the discovery and commercial development
of numerous therapeutic agents [12] afford reliably effective
treatment for many infectious diseases which had previously
caused extensive mortality and morbidity. In this context,
substituted s-triazine and benzenesulfonamide derivatives have
received considerable attention due to their signiﬁcant
activities like antimicrobial [2,3,8,22,23], antibacterial [11],
antifungal [19], antitumor [4,18], anti-inﬂammatory [17],
S26 N.C. Desai et al.anticancer [3,10,15,20], antiprotozoals [21], antimalarials
[1,3,14]. Profound medicinal applications associated with
isonicotinohydrazide render them as useful structural units in
drug research [13].
Due to rapid development of drug resistance, tolerance and
side effects there is a fundamental and critical need for the
development of a new generation of antimicrobial agents
which would exhibit improved pharmacological properties
and drug-resistance proﬁles. Previously, our research group
has also reported synthesis, characterization and antimicrobial
evaluation of N0-(4-(arylamino)-6-(thiazol-2-ylamino)-1,3,5-
triazin-2-yl)isonicotinohydrazide derivatives [5]. Keeping this
in mind we have subsequently carried out the synthesis of s-tri-
azine based isoniazid and benzenesulfonamide derivatives to
explore the synthesis of more potential bioactive molecules in
one framework.
2. Experimental part
2.1. Materials and physical measurements
The completion of reaction and purity of compounds were
checked on aluminum coated TLC plates 60 F245 (E.
Merck) using n-hexane:ethyl acetate (7.5:2.5 V/V) as mobile
phase and visualized under ultraviolet (UV) light or in an
iodine chamber. Melting points were determined on an elec-
tro thermal melting point apparatus and were reported
uncorrected. Elemental analysis (% C, H, N) was carried
out by a Perkin–Elmer 2400 CHN analyzer. IR spectra of
all the compounds were recorded on a Perkin–Elmer FT-
IR spectrophotometer in KBr. 1H NMR (300 MHz) and
13C NMR (100 MHz) spectra were recorded on Bruker
spectrometer using DMSO-d6 as solvent and TMS as an
internal standard. Mass spectra were obtained on SHIMA-
DZU LC–MS 2010 spectrophotometer. In the conventional
method, compounds were synthesized using Random
synthesizer.
2.2. Preparation of N0-(4,6-dichloro-1,3,5-triazin-2-
yl)isonicotinohydrazide (1)
A mixture of 2,4,6-trichloro-1,3,5-triazine (0.01 mol) in ace-
tone (15 mL) and isoniazid (0.01 mol) was taken in a conical
ﬂask. To this mixture, 4% NaOH was added drop-wise at 0–
5 C temperature. The solution was stirred for 2 h. The reac-
tion mixture was then poured onto crushed ice with constant
stirring and neutralized with dil. HCl. The solid formed was
ﬁltered, washed with water, dried and recrystallized from ace-
tone. Yield: 80.0%; m.p.: 180 C; IR (KBr, m, cm1): 780 (C–
Cl, Stretching), 1587 (N–H, bending), 1640 (C‚C, stretch-
ing), 1690 (C‚O, stretching), 1890 (C‚N, stretching), 3444
(N–H, stretching in amine); 1H NMR (300 MHz, DMSO-
d6, d, ppm): 6.72 (s, 1H, triazine-NH–NH–), 7.82 (d, 2H,
J= 7.9 Hz, C3-H & C5-H pyridine ring), 8.89 (d, 2H,
J= 7.8 Hz, C2-H & C6-H pyridine ring), 9.74 (s, 1H,
–NH–CO–); 13C NMR (100 MHz, DMSO-d6, d, ppm):
164.9 (1C, C‚O), 169.2 (2C, C–Cl), 184.8 (1C, C–NH– tri-
azine ring); LC–MS (m/z): 284.0 (M+), Anal. Calcd. For
C9H6Cl2N6O, C – 37.92, H – 2.12, N – 29.48; Found: C –
37.93, H – 2.10, N – 29.45%.2.3. Preparation of 4-(4-chloro-6-(2-isonicotinoylhydrazinyl)-
1,3,5-triazine-2-ylamino)-N-(pyrimidine-2-
yl)benzenesulfonamide (2)
A mixture of N0-(4,6-dichloro-1,3,5-triazine-2-yl) ison-
icotinohydrazide (0.01 mol) in acetone (15 mL) and 4-amino-
N-(pyrimidine-2-yl)benzenesulfonamide (0.01 mol) was taken
in a conical ﬂask. To this mixture, 4% NaOH was added drop-
wise at room temperature and was stirred for 3 h. The reaction
mixture was then poured onto crushed ice with constant stir-
ring and neutralized with dil. HCl. The solid obtained was ﬁl-
tered, washed with water, dried and recrystallized from 1,4-
dioxane. Yield: 70.0%; m.p.: 235 C; IR (KBr, m, cm1): 788
(C–Cl, Stretching), 895 (S–N, stretching), 1135 (S‚O, stretch-
ing in SO2), 1592 (N–H, bending), 1640 (C‚C, stretching),
1690 (C‚O, stretching), 1890 (C‚N, stretching), 3035 (C–
H, stretching in aromatic), 3445 (N–H, stretching in amine);
1H NMR (300 MHz, DMSO-d6, d, ppm): 6.54 (s, 2H, Ar–
NH–triazine), 6.72 (s, 1H, triazine–NH–NH–), 6.93 (t, 1H,
pyrimidine), 7.1–7.83 (d, 4H, Ar–H), 7.86 (d, 2H,
J= 8.0 Hz, C3-H & C5-H pyridine ring), 8.03 (s, 1H, –SO2–
NH–), 8.87 (d, 2H, pyrimidine), 8.95 (d, 2H, J= 7.7 Hz, C2-
H & C6-H pyridine ring), 9.78 (s, 1H, –NH–CO–);
13C NMR
(100 MHz, DMSO-d6, d, ppm): 164.1 (1C, C–NH– attached
with arylsulfonamide group), 164.6 (1C, C‚O), 166.4 (1C,
C–Cl), 169.2 (1C, C–NHSO2–), 169.9 (1C, C–NH–), 181.4
(1C, C–NHNHCO– triazine ring); LC–MS (m/z): 498.07
(M+), Anal. Calcd. For C19H15ClN10O3S, C – 45.74, H –
3.03, N – 28.07; Found: C – 45.75, H – 3.01, N – 28.04%.
2.4. Preparation of 4-(4-(2-isonicotinoylhydrazinyl)-6-
((aryl)amino)-1,3,5-triazin-2-ylamino)-N-(pyrimidin-2-
yl)benzenesulfonamide (3a–v)
Intermediate compound 4-(4-chloro-6-(2-isonicotinoylhydrazi-
nyl)-1,3,5-triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfon-
amide (2) (0.01 mol) in 1,4-dioxane (20 mL) was taken in a
round bottom ﬂask and different aromatic amines (0.01 mol)
were added to it. To this mixture, 8% NaOH was added drop-
wise and it was then reﬂuxed for 2–4 h. Finally the reaction
mixture was poured onto crushed ice with constant stirring
and neutralized with dil. HCl. The product formed was ﬁl-
tered, washed with cold water, dried and recrystallized from
methanol.
2.4.1. Physical constants and characterization of 4-(4-(2-
isonicotinoylhydrazinyl)-6-(phenyl amino)-1,3,5-triazin-2-
ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3a)
Yield: 63.0%; m.p.: 265–268 C; IR (KBr, m, cm1): 795 (C–H,
bending in aromatic), 895 (S–N, stretching), 1120 (S‚O,
stretching in SO2), 1592 (N–H, bending), 1640 (C‚C, stretch-
ing), 1690 (C‚O, stretching), 1890 (C‚N, stretching), 3020
(C–H, stretching in aromatic ring), 3038 (C–H, stretching in
aromatic), 3448 (N–H, stretching in amine); 1H NMR
(300 MHz, DMSO-d6, d, ppm): 6.64 (s, 2H, Ar–NH–triazine),
6.82 (s, 1H, triazine–NH–NH–), 6.91 (t, 1H, pyrimidine), 7.02–
7.62 (m, 9H, Ar–H), 7.84 (d, 2H, J= 7.8 Hz, C3-H & C5-H
pyridine ring), 8.13 (s, 1H, –SO2–NH–), 8.84 (d, 2H, pyrimi-
dine), 8.98 (d, 2H, J= 7.9 Hz, C2-H & C6-H pyridine ring),
9.78 (s, 1H, –NH–CO–); 13C NMR (100 MHz, DMSO-d6, d,
Synthesis of benzenesulfonamide derivatives S27ppm): 164.1 (1C, C–NH– attached with arylsulfonamide
group), 164.4 (1C, C‚O), 168.9 (1C, C–NH–Ar), 169.3
(1C, C–NHSO2–), 176.7 (1C, C–NHNHCO– triazine ring);
LC–MS (m/z): 555.15 (M+), Anal. Calcd. For C25H21N11O3S,
C – 54.05, H – 3.81, N – 27.73; Found: C – 54.12, H – 3.90,
N – 27.67%.
2.4.2. Physical constants and characterization of 4-(4-(4-
bromophenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide(3b)
Yield: 72.0%, m.p. 259 C; IR (KBr, m, cm1): 530 (C–Br,
stretching), 780 (C–H, bending in aromatic), 898 (S–N, stretch-
ing), 1158 (S‚O, stretching in SO2), 1592 (N–H, bending),
1648 (C‚C, stretching), 1730 (C‚O, stretching), 1890
(C‚N, stretching), 3025 (C–H, stretching in aromatic), 3059
(C–H, stretching in aromatic ring), 3447 (N–H, stretching in
amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 6.67 (s,
2H, Ar–NH–triazine), 6.84 (s, 1H, triazine–NH–NH–), 6.92
(t, 1H, pyrimidine), 7.03–7.64 (m, 8H, Ar–H), 7.86 (d, 2H,
J= 7.9 Hz, C3-H & C5-H pyridine ring), 8.14 (s, 1H, –SO2–
NH–), 8.87 (d, 2H, pyrimidine), 8.95 (d, 2H, J= 7.6 Hz,
C2-H & C6-H pyridine ring), 9.82 (s, 1H, –NH–CO–);
13C NMR (100 MHz, DMSO-d6, d, ppm): 164.3 (1C,
C–NH– attached with arylsulfonamide group), 164.9 (1C,
C‚O), 168.7 (1C, C–NH–Ar), 169.4 (1C, C–NHSO2–),
176.8 (1C, C–NHNHCO– triazine ring); LC–MS (m/z):
635.06 (M+), Anal. Calcd. For: C25H20BrN11O3S, C – 47.33,
H – 3.18, N – 24.28; Found: C – 47.23, H – 3.20, N – 24.38%.
2.4.3. Physical constants and characterization of 4-(4-(2-
chlorophenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide(3c)
Yield: 78.0%, m.p. 270 C; IR (KBr, m, cm1): 643 (C–Cl,
stretching), 780 (C–H, bending in aromatic), 898 (S–N, stretch-
ing), 1156 (S‚O, stretching in SO2), 1602 (N–H, bending),
1648 (C‚C, stretching), 1730 (C‚O, stretching), 1890
(C‚N, stretching), 3038 (C–H, stretching in aromatic), 3458
(N–H, stretching in amine); 1H NMR (300 MHz, DMSO-d6,
d, ppm): 6.64 (s, 2H, Ar–NH–triazine), 6.82 (s, 1H, triazine–
NH–NH–), 6.99 (t, 1H, pyrimidine), 7.08–7.84 (m, 7H, Ar–
H), 7.87 (d, 2H, J= 7.9 Hz, C3-H & C5-H pyridine ring),
8.13 (s, 1H, –SO2–NH–), 8.81 (d, 2H, pyrimidine), 8.94 (d,
2H, J= 7.6 Hz, C2-H & C6-H pyridine ring), 9.81 (s, 1H,
–NH–CO–); 13C NMR (100 MHz, DMSO-d6, d, ppm): 164.2
(1C, C–NH– attached with arylsulfonamide group), 164.8
(1C, C‚O), 168.8 (1C, C–NH–Ar), 169.6 (1C, C–NHSO2–),
176.9 (1C, C–NHNHCO– triazine ring); LC–MS (m/z):
589.12 (M+), Anal. Calcd. For: C25H20ClN11O3S, C – 50.89,
H – 3.42, N – 26.11; Found: C – 50.87, H – 3.41, N – 26.14%.
2.4.4. Physical constants and characterization of 4-(4-(3-
chlorophenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide(3d)
Yield: 69.0%, m.p. 292 C; IR (KBr, m, cm1): 675 (C–Cl,
stretching), 1738 (C‚O, stretching), 784 (C–H, bending in
aromatic), 889 (S–N, stretching), 1153 (S‚O, stretching in
SO2), 1612 (N–H, bending), 1645 (C‚C, stretching), 1892
(C‚N, stretching), 3057 (C–H, stretching in aromatic ring),
3445 (N–H, stretching in amine); 1H NMR (300 MHz,
DMSO-d6, d, ppm): 6.65 (s, 2H, Ar–NH–triazine), 6.85 (s,
1H, triazine–NH–NH–), 6.94 (t, 1H, pyrimidine), 7.07–7.67(m, 7H, Ar–H), 7.78 (s, 1H, Ar–H), 7.88 (d, 2H, J= 7.8 Hz,
C3-H & C5-H pyridine ring), 8.11 (s, 1H, –SO2–NH–), 8.84
(d, 2H, pyrimidine), 8.96 (d, 2H, J= 7.9 Hz, C2-H & C6-H
pyridine ring), 9.83 (s, 1H, –NH–CO–); 13C NMR
(100 MHz, DMSO-d6, d, ppm): 164.2 (1C, C–NH– attached
with arylsulfonamide group), 164.7 (1C, C‚O), 168.6 (1C,
C–NH–Ar), 169.6 (1C, C–NHSO2–), 176.7 (1C, C–
NHNHCO– triazine ring); LC–MS (m/z): 589.12 (M+), Anal.
Calcd. For: C25H20ClN11O3S, C – 50.89, H – 3.42, N – 26.11;
Found: C – 50.85, H – 3.44, N – 26.01%.
2.4.5. Physical constants and characterization of 4-(4-(4-
chlorophenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3e)
Yield: 70.0%, m.p. 250 C; IR (KBr, m, cm1): 680 (C–Cl,
stretching), 781 (C–H, bending in aromatic), 890 (S–N, stretch-
ing), 1160 (S‚O, stretching in SO2), 1612 (N–H, bending),
1658 (C‚C, stretching), 1890 (C‚N, stretching), 1742
(C‚O, stretching), 3042 (C–H, stretching in aromatic), 3059
(C–H, stretching in aromatic ring), 3449 (N–H, stretching in
amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 6.62 (s,
2H, Ar–NH–triazine), 6.83 (s, 1H, triazine–NH–NH–), 6.97
(t, 1H, pyrimidine), 7.13–7.65 (m, 8H, Ar–H), 7.87 (d, 2H,
J= 7.8 Hz, C3-H & C5-H pyridine ring), 8.15 (s, 1H,
–SO2–NH–), 8.83 (d, 2H, pyrimidine), 8.94 (d, 2H,
J= 7.7 Hz, C2-H & C6-H pyridine ring), 9.81 (s, 1H, –NH–
CO–); 13C NMR (100 MHz, DMSO-d6, d, ppm): 164.4 (1C,
C–NH– attached with arylsulfonamide group), 164.8 (1C,
C‚O), 168.8 (1C, C–NH–Ar), 169.5 (1C, C–NHSO2–),
176.7 (1C, C–NHNHCO– triazine ring); LC–MS (m/z):
589.12 (M+), Anal. Calcd. C25H20ClN11O3S, C – 50.89, H –
3.42, N – 26.11; Found: C – 50.77, H – 3.43, N – 26.11%.
2.4.6. Physical constants and characterization of 4-(4-(2,5-
dichlorophenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3f)
Yield: 69.0%, m.p. 240 C; IR (KBr, m, cm1): 658 (C–Cl,
stretching), 781 (C–H, bending in aromatic), 896 (S–N, stretch-
ing), 1151 (S‚O, stretching in SO2), 1615 (N–H, bending),
1657 (C‚C, stretching), 1747 (C‚O, stretching), 1889
(C‚N, stretching), 3047 (C–H, stretching in aromatic), 3062
(C–H, stretching in aromatic ring), 3449 (N–H, stretching in
amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 6.68 (s,
2H, Ar–NH–triazine), 6.85 (s, 1H, triazine–NH–NH–), 6.99
(t, 1H, pyrimidine), 7.09–7.64 (m, 6H, Ar-H), 7.76 (s, 1H,
Ar–H), 7.85 (d, 2H, J= 7.8 Hz, C3-H & C5-H pyridine ring),
8.17 (s, 1H, –SO2–NH–), 8.81 (d, 2H, pyrimidine), 8.97 (d, 2H,
J= 7.9 Hz, C2-H & C6-H pyridine ring), 9.86 (s, 1H, –NH–
CO–); 13C NMR (100 MHz, DMSO-d6, d, ppm): 164.5 (1C,
C–NH– attached with arylsulfonamide group), 164.7 (1C,
C‚O), 168.8 (1C, C–NH–Ar), 169.5 (1C, C–NHSO2–),
176.9 (1C, C–NHNHCO– triazine ring); LC–MS (m/z):
623.08 (M+), Anal. Calcd. For: C25H19Cl2N11O3S, C –
48.08, H – 3.07, N – 24.67; Found: C – 48.03, H – 3.07, N –
26.55%.
2.4.7. Physical constants and characterization of 4-(4-(2,6-
dichlorophenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide(3g)
Yield: 62.0%, m.p. 270 C; IR (KBr, m, cm1): 645 (C–Cl,
stretching), 789 (C–H, bending in aromatic), 894 (S–N, stretch-
S28 N.C. Desai et al.ing), 1157 (S‚O, stretching in SO2), 1622 (N–H, bending),
1659 (C‚C, stretching), 1750 (C‚O, stretching), 1885
(C‚N, stretching), 3050 (C–H, stretching in aromatic), 3082
(C–H, stretching in aromatic ring), 3453 (N–H, stretching in
amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 6.67 (s,
2H, Ar–NH–triazine), 6.88 (s, 1H, triazine–NH–NH–), 6.94
(t, 1H, pyrimidine), 7.01–7.65 (m, 7H, Ar–H), 7.83 (d, 2H,
J= 7.7 Hz, C3-H & C5-H pyridine ring), 8.18 (s, 1H, –SO2–
NH–), 8.84 (d, 2H, pyrimidine), 8.96 (d, 2H, J= 7.9 Hz,
C2-H & C6-H pyridine ring), 9.87 (s, 1H, –NH–CO–);
13C NMR (100 MHz, DMSO-d6, d, ppm): 164.6 (1C, C–NH– at-
tached with arylsulfonamide group), 164.7 (1C, C‚O), 168.5
(1C, C–NH–Ar), 169.2 (1C, C–NHSO2–), 176.5 (1C,
C–NHNHCO– triazine ring); LC–MS (m/z): 623.08 (M+),
Anal. Calcd. For: C25H19Cl2N11O3S, C – 48.08, H – 3.07, N
– 24.67; Found: C – 48.09, H – 3.13, N – 24.68%.
2.4.8. Physical constants and characterization of 4-(4-(4-
ﬂuorophenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-triazin-
2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide(3h)
Yield: 75.0%, m.p. 240 C; IR (KBr, m, cm1): 791 (C–H,
bending in aromatic), 908 (S–N, stretching), 1030 (C–F,
stretching), 1152 (S‚O, stretching in SO2), 1622 (N–H, bend-
ing), 1652 (C‚C, stretching), 1753 (C‚O, stretching), 1875
(C‚N, stretching), 3050 (C–H, stretching in aromatic), 3093
(C–H, stretching in aromatic ring), 3462 (N–H, stretching in
amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 6.66 (s,
2H, Ar–NH–triazine), 6.84 (s, 1H, triazine–NH–NH–), 6.97
(t,1H, pyrimidine), 7.12–7.83 (m, 8H, Ar–H), 7.89 (d, 2H,
J= 7.9 Hz, C3-H & C5-H pyridine ring), 8.16 (s, 1H, –SO2–
NH–), 8.83 (d, 2H, pyrimidine), 8.98 (d, 2H, J= 7.7 Hz, C2-
H & C6-H pyridine ring), 9.89 (s, 1H, –NH–CO–);
13C NMR
(100 MHz, DMSO-d6, d, ppm): 164.2 (1C, C–NH– attached
with arylsulfonamide group), 164.8 (1C, C‚O), 168.6 (1C,
C–NH–Ar), 169.5 (1C, C–NHSO2–), 176.4 (1C, C–
NHNHCO– triazine ring); LC–MS (m/z): 573.15 (M+), Anal.
Calcd. For: C25H20FN11O3S, C – 52.35, H – 3.51, N – 26.86;
Found: C – 52.37, H – 3.50, N – 26.89%.
2.4.9. Physical constants and characterization of 4-(4-(2-
isonicotinoylhydrazinyl)-6-(o-tolylamino)-1,3,5-triazin-2-
ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3i)
Yield: 78.0%, m.p. 260 C; IR (KBr, m, cm1): 710 (C–H,
bending in aromatic), 902 (S–N, stretching), 1149 (S‚O,
stretching in SO2), 1622 (N–H, bending), 1651 (C‚C,
stretching), 1749 (C‚O, stretching), 1872 (C‚N, stretching),
3462 (N–H, stretching in amine), 3050 (C–H, stretching in
aromatic), 2890 (C–H, stretching in –CH3), 3086 (C–H,
stretching in aromatic ring); 1H NMR (DMSO-d6, d, ppm):
2.12 (s, 3H, –CH3), 6.61 (s, 2H, Ar–NH–triazine), 6.80 (s,
1H, triazine–NH–NH–), 6.90 (t, 1H, pyrimidine), 6.98–7.77
(m, 8H, Ar–H), 7.86 (d, 2H, J= 7.7 Hz, C3-H & C5-H pyr-
idine ring), 8.10 (s, 1H, –SO2–NH–), 8.85 (d, 2H, pyrimidine),
8.94 (d, 2H, J= 7.9 Hz, C2-H & C6-H pyridine ring), 9.87 (s,
1H, –NH–CO–); 13C NMR (100 MHz, DMSO-d6, d, ppm):
17.8 (1C, –CH3), 164.2 (1C, C–NH– attached with arylsulf-
onamide group), 164.6 (1C, C‚O), 168.4 (1C, C–NH–Ar),
169.6 (1C, C–NHSO2–), 176.5 (1C, C–NHNHCO– triazine
ring); LC–MS (m/z): 569.17 (M+), Anal. Calcd. For:
C26H23N11O3S, C – 54.82, H – 4.07, N – 27.05; Found:
C – 54.85, H – 4.05, N – 27.08%.2.4.10. Physical constants and characterization of 4-(4-(2-
isonicotinoylhydrazinyl)-6-(p-tolylamino)-1,3,5-triazin-2-
ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3j)
Yield: 73.0%, m.p. 225 C; IR (KBr, m, cm1): 715 (C–H,
bending in aromatic), 905 (S–N, stretching), 1153 (S‚O,
stretching in SO2), 1628 (N–H, bending), 1649 (C‚C, stretch-
ing), 1753 (C‚O, stretching), 1868 (C‚N, stretching), 2879
(C–H, stretching in –CH3), 3048 (C–H, stretching in aromatic),
3091 (C–H, stretching in aromatic ring), 3458 (N–H, stretching
in amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 2.07 (s,
3H, –CH3), 6.60 (s, 2H, Ar–NH–triazine), 6.79 (s, 1H, tri-
azine-NH–NH–), 6.89 (t, 1H, pyrimidine), 7.04–7.73 (m, 8H,
Ar–H), 7.87 (d, 2H, J= 7.9 Hz, C3-H & C5-H pyridine ring),
8.08 (s, 1H, –SO2–NH–), 8.86 (d, 2H, pyrimidine), 8.94 (d, 2H,
J= 7.9 Hz, C2-H & C6-H pyridine ring), 9.80 (s, 1H, –NH–
CO–); 13C NMR (100 MHz, DMSO-d6, d, ppm): 21.6
(1C, –CH3), 164.0 (1C, C–NH– attached with arylsulfonamide
group), 164.8 (1C, C‚O), 168.9 (1C, C–NH–Ar), 169.7 (1C,
C–NHSO2–), 176.4 (1C, C–NHNHCO– triazine ring); LC–
MS (m/z): 569.17 (M+), Anal. Calcd. For: C26H23N11O3S, C
– 54.82, H – 4.07, N – 27.05; Found: C – 54.84, H – 4.05, N
– 27.09%.
2.4.11. Physical constants and characterization of 4-(4-(2,4-
dimethylphenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3k)
Yield: 80.0%, m.p. 200 C; IR (KBr, m, cm1): 715 (C–H,
bending in aromatic), 910 (S–N, stretching), 1158 (S‚O,
stretching in SO2), 1622 (N–H, bending), 1648 (C‚C, stretch-
ing), 1762 (C‚O, stretching), 1862 (C‚N, stretching), 2882
(C–H, stretching in –CH3), 3057 (C–H, stretching in aromatic),
3089 (C–H, stretching in aromatic ring), 3452 (N–H, stretching
in amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 2.13 (s,
3H, p-CH3), 2.35 (s, 3H, o-CH3), 6.58 (s, 2H, Ar–NH–tri-
azine), 6.80 (s, 1H, triazine–NH–NH–), 6.91 (t, 1H, pyrimi-
dine), 6.95–7.62 (m, 7H, Ar–H), 7.80 (d, 2H, J= 7.7 Hz,
C3-H & C5-H pyridine ring), 8.07 (s, 1H, –SO2–NH–), 8.82
(d, 2H, pyrimidine), 8.92 (d, 2H, J= 8.0 Hz, C2-H & C6-H
pyridine ring), 9.79 (s, 1H, –NH–CO–); 13C NMR
(100 MHz, DMSO-d6, d, ppm): 17.7 (1C, o-CH3), 21.4 (1C,
p-CH3), 164.2 (1C, C–NH– attached with arylsulfonamide
group), 164.7 (1C, C‚O), 168.5 (1C, C–NH–Ar), 169.3 (1C,
C–NHSO2–), 176.6 (1C, C–NHNHCO– triazine ring); LC–
MS (m/z): 583.19 (M+), Anal. Calcd. For: C27H25N11O3S, C
– 55.56, H – 4.32, N – 26.40; Found: C – 55.55, H – 4.30, N
– 26.42%.
2.4.12. Physical constants and characterization of 4-(4-(2,6-
dimethylphenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3l)
Yield: 78.0%, m.p. 282 C; IR (KBr, m, cm1): 720 (C–H,
bending in aromatic), 912 (S–N, stretching), 1149 (S‚O,
stretching in SO2), 1629 (N–H, bending), 1651 (C‚C, stretch-
ing), 1771 (C‚O, stretching),1867 (C‚N, stretching), 2878
(C–H, stretching in –CH3), 3062 (C–H, stretching in aromatic),
3091 (C–H, stretching in aromatic ring), 3445 (N–H, stretching
in amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 2.13 (s,
6H, –CH3), 6.60 (s, 2H, Ar–NH–triazine), 6.79 (s, 1H, tri-
azine–NH–NH–), 6.89 (t, 1H, pyrimidine), 6.96–7.61 (m, 7H,
Ar–H), 7.82 (d, 2H, J= 7.6 Hz, C3-H & C5-H pyridine ring),
8.06 (s, 1H, –SO2–NH–), 8.82 (d, 2H, pyrimidine), 8.91 (d, 2H,
Synthesis of benzenesulfonamide derivatives S29J= 7.7 Hz, C2-H & C6-H pyridine ring), 9.80 (s, 1H, –NH–
CO–); 13C NMR (100 MHz, DMSO-d6, d, ppm): 17.6
(2C, –CH3), 164.2 (1C, C–NH– attached with arylsulfonamide
group), 164.8 (1C, C‚O), 168.4 (1C, C–NH–Ar), 169.7 (1C,
C–NHSO2–), 176.9 (1C, C–NHNHCO– triazine ring); LC–
MS (m/z): 583.19 (M+), Anal. Calcd. For: C27H25N11O3S,
C – 55.56, H – 4.32, N – 26.40; Found: C – 55.55, H – 4.34,
N – 26.41%.
2.4.13. Physical constants and characterization of 4-(4-(2-
isonicotinoylhydrazinyl)-6-((3-(triﬂuoromethyl)phenylamino)-
1,3,5-triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide
(3m)
Yield: 68.0%, m.p. 300 C; IR (KBr, m, cm1): 727 (C–H, bend-
ing in aromatic), 918 (S–N, stretching), 1035 (C–F, stretching),
1147 (S‚O, stretching in SO2), 1632 (N–H, bending),
1657(C‚C, stretching), 1782 (C‚O, stretching), 1864 (C‚N,
stretching), 2879 (C–H, stretching in –CH3), 3092 (C–H, stretch-
ing in aromatic ring), 3455 (N–H, stretching in amine); 1HNMR
(300 MHz, DMSO-d6, d, ppm): 6.68 (s, 2H, Ar–NH–triazine),
6.86 (s, 1H, triazine–NH–NH–), 6.98 (t, 1H, pyrimidine),
7.08–7.65 (m, 7H, Ar–H), 7.71 (s, 1H, Ar–H), 7.87 (d, 2H,
J= 7.9 Hz, C3-H & C5-H pyridine ring), 8.16 (s, 1H, –SO2–
NH–), 8.88 (d, 2H, pyrimidine), 8.98 (d, 2H, J= 7.5 Hz, C2-H
& C6-H pyridine ring), 9.89 (s, 1H, –NH–CO–);
13C NMR
(100 MHz, DMSO-d6, d, ppm): 124.4 (1C, –CF3), 164.1 (1C,
C–NH– attached with arylsulfonamide group), 164.8 (1C,
C‚O), 168.4 (1C, C–NH–Ar), 169.6 (1C, C–NHSO2–), 176.5
(1C, C–NHNHCO– triazine ring); LC–MS (m/z): 623.14
(M+), Anal. Calcd. For: C26H20F3N11O3S, C – 50.08, H –
3.23, N – 24.71; Found: C – 50.16, H – 3.25, N – 24.75%.
2.4.14. Physical constants and characterization of 4-(4-(2-
isonicotinoylhydrazinyl)-6-((4-(triﬂuoromethyl)phenylamino)-
1,3,5-triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide
(3n)
Yield: 63.0%, m.p. 275 C; IR (KBr, m, cm1): 730 (C–H,
bending in aromatic), 917 (S–N, stretching), 1015 (C–F,
stretching), 1152 (S‚O, stretching in SO2), 1628 (N–H, bend-
ing), 1639 (N–H, bending), 1649 (C‚C, stretching), 1785
(C‚O, stretching), 1862 (C‚N, stretching), 2875 (C–H,
stretching in –CH3), 3098 (C–H, stretching in aromatic ring),
3451 (N–H, stretching in amine); 1H NMR (300 MHz,
DMSO-d6, d, ppm): 6.64 (s, 2H, Ar–NH–triazine), 6.84 (s,
1H, triazine–NH–NH–), 6.95 (t, 1H, pyrimidine), 7.11–7.67
(m, 8H, Ar–H), 7.88 (d, 2H, J= 7.9 Hz, C3-H & C5-H pyri-
dine ring), 8.15 (s, 1H, –SO2–NH–), 8.89 (d, 2H, pyrimidine),
8.97 (d, 2H, J= 7.8 Hz, C2-H & C6-H pyridine ring), 9.87
(s, 1H, –NH–CO–); 13C NMR (100 MHz, DMSO-d6, d,
ppm): 124.5 (1C, –CF3), 164.0 (1C, C–NH– attached with aryl-
sulfonamide group), 164.7 (1C, C‚O), 168.5 (1C, C–NH–Ar),
169.4 (1C, C–NHSO2–), 176.9 (1C, C–NHNHCO– triazine
ring); LC–MS (m/z): 623.14 (M+), Anal. Calcd. For:
C26H20F3N11O3S, C – 50.08, H – 3.23, N – 24.71; Found:
C – 50.06, H – 3.21, N – 24.72%.
2.4.15. Physical constants and characterization of 4-(4-(2-
isonicotinoylhydrazinyl)-6-(4-methoxyphenylamino)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3o)
Yield: 69.0%, m.p. 220 C; IR (KBr, m, cm1): 730 (C–H,
bending in aromatic), 917 (S–N, stretching), 1013 (C–F,stretching), 1152 (S‚O, stretching in SO2), 1629 (N–H, bend-
ing), 1632 (N–H, bending), 1649 (C‚C, stretching), 1785
(C‚O, stretching), 1862 (C‚N, stretching), 2835 (C–H,
stretching in C–O–CH3), 3098 (C–H, stretching in aromatic
ring), 3449 (N–H, stretching in amine); 1H NMR (300 MHz,
DMSO-d6, d, ppm): 3.82 (s, 3H, –OCH3), 6.60 (s, 2H, Ar–
NH–triazine), 6.80 (s, 1H, triazine–NH–NH–), 6.91 (t, 1H,
pyrimidine), 7.03–7.73 (m, 8H, Ar–H), 7.84 (d, 2H,
J= 7.7 Hz, C3-H & C5-H pyridine ring), 8.09 (s, 1H, –SO2–
NH–), 8.82 (d, 2H, pyrimidine), 8.94 (d, 2H, J= 7.7 Hz,
C2-H & C6-H pyridine ring), 9.80 (s, 1H, –NH–CO–);
13C
NMR (100 MHz, DMSO-d6, d, ppm): 55.4 (1C, –OCH3),
164.0 (1C, C–NH– attached with arylsulfonamide group),
164.3 (1C, C‚O), 168.5 (1C, C–NH–Ar), 169.6 (1C, C–
NHSO2–), 176.5 (1C, C–NHNHCO– triazine ring); LC–MS
(m/z): 585.17 (M+), Anal. Calcd. For: C26H23N11O4S,
C – 53.33, H – 3.96, N – 26.31; Found: C – 53.31, H – 3.93,
N – 26.28%.
2.4.16. Physical constants and characterization of 4-(4-(2,4-
dimethoxyphenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide(3p)
Yield: 67.0%, m.p. 289 C; IR (KBr, m, cm1): 728 (C–H,
bending in aromatic), 919 (S–N, stretching), 1151 (S‚O,
stretching in SO2), 1624 (N–H, bending), 1644 (C‚C, stretch-
ing), 1779 (C‚O, stretching), 1859 (C‚N, stretching), 2835
(C–O–CH3, stretching), 2871 (C–H, stretching in –CH3),
3092 (C–H, stretching in aromatic ring), 3438 (N–H, stretching
in amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 3.83 (s,
6H, –OCH3), 6.59 (s, 2H, Ar–NH–triazine), 6.79 (s, 1H, tri-
azine–NH–NH–), 6.89 (t, 1H, pyrimidine), 7.01–7.62 (m, 6H,
Ar–H), 7.72 (s, 1H, Ar–H), 7.81 (d, 2H, J= 7.7 Hz, C3-H &
C5-H pyridine ring), 8.07 (s, 1H, –SO2–NH–), 8.82 (d, 2H,
pyrimidine), 8.92 (d, 2H, J= 7.9 Hz, C2-H & C6-H pyridine
ring), 9.78 (s, 1H, –NH–CO–); 13C NMR (100 MHz,
DMSO-d6, d, ppm): 52.8 (1C, o-OCH3), 55.7 (1C, p-OCH3),
164.0 (1C, C–NH– attached with arylsulfonamide group),
164.6 (1C, C‚O), 168.5 (1C, C–NH–Ar), 169.3 (1C,
C–NHSO2–), 176.6 (1C, C–NHNHCO– triazine ring);
LC–MS (m/z): 615.18 (M+), Anal. Calcd. For: C27H25N11O5S,
C – 52.68, H – 4.09, N – 25.03; Found: C – 52.67, H – 4.08,
N – 25.05%.
2.4.17. Physical constants and characterization of 4-(4-
ethoxyphenylamino)-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3q)
Yield: 59.0%, m.p. 304 C; IR (KBr, m, cm1): 723 (C–H,
bending in aromatic), 925 (S–N, stretching), 1156 (S‚O,
stretching in SO2), 1173 (C–O, stretching in C–O–C), 1628
(N–H, bending), 1638 (N–H, bending), 1642 (C‚C, stretch-
ing), 1781 (C‚O, stretching), 1852 (C‚N, stretching), 2873
(C–H, stretching in –CH3), 3084 (C–H, stretching in aromatic
ring), 3431 (N–H, stretching in amine); 1H NMR (300 MHz,
DMSO-d6, d, ppm): 1.31 (t, 3H, –OCH2CH3), 4.08 (q, 2H,
–OCH2CH3), 6.60 (s, 2H, Ar–NH–triazine), 6.79 (s, 1H, tri-
azine–NH–NH–), 6.92 (t, 1H, pyrimidine), 7.08–7.68 (m, 8H,
Ar–H), 7.81 (d, 2H, J= 7.6 Hz, C3-H & C5-H pyridine ring),
8.08 (s, 1H, –SO2–NH–), 8.83 (d, 2H, pyrimidine), 8.90 (d, 2H,
J= 7.7 Hz, C2-H & C6-H pyridine ring), 9.79 (s, 1H,
–NH–CO–); 13C NMR (100 MHz, DMSO-d6, d, ppm): 14.6
(1C, –OCH2CH3), 64.9 (1C, –OCH2CH3), 164.2 (1C, C–NH–
S30 N.C. Desai et al.attached with arylsulfonamide group), 164.8 (1C, C‚O), 168.3
(1C, C–NH–Ar), 169.6 (1C, C–NHSO2–), 176.4 (1C,
C–NHNHCO– triazine ring); LC–MS (m/z): 599.18 (M+),
Anal. Calcd. For: C27H25N11O4S, C – 54.08, H – 4.20,
N – 25.70; Found: C – 54.07, H – 4.21, N – 25.70%.
2.4.18. Physical constants and characterization of 4-(4-(2-
isonicotinoylhydrazinyl)-6-(2-nitrophenylamino)-1,3,5-triazin-
2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3r)
Yield: 70.0%, m.p. 269 C; IR (KBr, m, cm1): 728 (C–H,
bending in aromatic), 929 (S–N, stretching), 1154 (S‚O,
stretching in SO2), 1582 (C–NO2, stretching), 1632, (N–H,
bending), 1641 (C‚C, stretching), 1778 (C‚O, stretching),
1851 (C‚N, stretching), 2878 (C–H, stretching in –CH3),
3081 (C–H, stretching in aromatic ring), 3441 (N–H, stretching
in amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 6.67 (s,
2H, Ar–NH–triazine), 6.86 (s, 1H, triazine–NH–NH–), 6.95
(t, 1H, pyrimidine), 7.07–7.69 (m, 8H, Ar-H), 7.89 (d, 2H,
J= 7.8 Hz, C3-H & C5-H pyridine ring), 8.17 (s, 1H, –SO2–
NH–), 8.88 (d, 2H, pyrimidine), 8.99 (d, 2H, J= 8.0 Hz,
C2-H & C6-H pyridine ring), 9.91 (s, 1H, –NH–CO–);
13C
NMR (100 MHz, DMSO-d6, d, ppm): 164.2 (1C, C–NH– at-
tached with arylsulfonamide group), 164.8 (1C, C‚O), 168.6
(1C, C–NH–Ar), 169.5 (1C, C–NHSO2–), 176.6 (1C,
C–NHNHCO– triazine ring); LC–MS (m/z): 600.14 (M+),
Anal. Calcd. For: C25H20N12O5S, C – 50.00, H – 3.36,
N – 27.99; Found: C – 50.01, H – 3.35, N – 27.99%.
2.4.19. Physical constants and characterization of 4-(4-(2-
isonicotinoylhydrazinyl)-6-(3-nitrophenylamino)-1,3,5-triazin-
2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3s)
Yield: 65.0%, m.p. 298 C; IR (KBr, m, cm1): 732 (C–H,
bending in aromatic), 923 (S–N, stretching), 1142 (S‚O,
stretching in SO2), 1573 (C–NO2, stretching), 1635 (N–H,
bending), 1644 (C‚C, stretching), 1775 (C‚O, stretching),
1853 (C‚N, stretching), 2883 (C–H, stretching in –CH3),
3088 (C–H, stretching in aromatic ring), 3442 (N–H, stretching
in amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 6.66 (s,
2H, Ar–NH–triazine), 6.86 (s, 1H, triazine–NH–NH–), 6.97
(t, 1H, pyrimidine), 7.13–7.75 (m, 7H, Ar–H), 7.81 (s, 1H,
Ar–H), 7.88 (d, 2H, J= 7.9 Hz, C3-H & C5-H pyridine ring),
8.16 (s, 1H, –SO2–NH–), 8.87 (d, 2H, pyrimidine), 8.98 (d, 2H,
J= 7.8 Hz, C2-H & C6-H pyridine ring), 9.89 (s, 1H, –NH–
CO–); 13C NMR (100 MHz, DMSO-d6, d, ppm): 164.0 (1C,
C–NH– attached with arylsulfonamide group), 164.7 (1C,
C‚O), 168.6 (1C, C–NH–Ar), 169.2 (1C, C–NHSO2–),
176.3 (1C, C–NHNHCO– triazine ring); LC–MS (m/z):
600.14 (M+), Anal. Calcd. For: C25H20N12O5S, C – 50.00,
H – 3.36, N – 27.99; Found: C – 50.00, H – 3.38, N – 27.97%.
2.4.20. Physical constants and characterization of 4-(4-(2-
isonicotinoylhydrazinyl)-6-(4-nitrophenylamino)-1,3,5-triazin-
2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (3t)
Yield: 63.0%, m.p. 301 C; IR (KBr, m, cm1): 733 (C–H,
bending in aromatic), 924 (S–N, stretching), 1146 (S‚O,
stretching in SO2), 1569 (C–NO2, stretching), 1637 (N–H,
bending), 1641 (C‚C, stretching), 1773 (C‚O, stretching),
1851 (C‚N, stretching), 2881 (C–H, stretching in –CH3),
3091 (C–H, stretching in aromatic ring), 3441 (N–H, stretching
in amine); 1H NMR (300 MHz, DMSO-d6, d, ppm): 6.65 (s,
2H, Ar–NH–triazine), 6.85 (s, 1H, triazine–NH–NH–), 6.97(t, 1H, pyrimidine), 7.18–7.78 (m, 8H, Ar–H), 7.86 (d, 2H,
J= 7.8 Hz, C3-H & C5-H pyridine ring), 8.16 (s, 1H, –SO2–
NH–), 8.85 (d, 2H, pyrimidine), 8.96 (d, 2H, J= 7.7 Hz, C2-
H & C6-H pyridine ring), 9.87 (s, 1H, –NH–CO–);
13C NMR
(100 MHz, DMSO-d6, d, ppm): 164.2 (1C, C–NH– attached
with arylsulfonamide group), 164.6 (1C, C‚O), 168.4 (1C,
C–NH–Ar), 169.3 (1C, C–NHSO2–), 176.5 (1C, C–
NHNHCO– triazine ring); LC–MS (m/z): 600.14 (M+), Anal.
Calcd. For: C25H20N12O5S, C – 50.00, H – 3.36, N – 27.99;
Found: C – 50.03, H – 3.35, N – 27.95%.
2.4.21. Physical constants and characterization of 4-(4-(2-
isonicotinoylhydrazinyl)-6-(4-N-(pyrimidin-2-
ylsulfamoyl)phenylamino)-1,3,5-triazin-2-ylamino)benzoic acid
(3u)
Yield: 58.0%, m.p. 279 C; IR (KBr, m, cm1): 739 (C–H,
bending in aromatic), 924 (S–N, stretching), 948 (O–H, bend-
ing), 1149 (S‚O, stretching in SO2), 1639 (N–H, bending),
1649 (C‚C, stretching), 1731 (C‚O, stretching), 1854
(C‚N, stretching), 2780 (O–H, stretching), 2878 (C–H,
stretching in –CH3), 3093 (C–H, stretching in aromatic ring),
3444 (N–H, stretching in amine); 1H NMR (300 MHz,
DMSO-d6, d, ppm): 6.67 (s, 2H, Ar–NH–triazine), 6.88 (s,
1H, triazine–NH–NH–), 6.98 (t, 1H, pyrimidine), 7.14–7.76
(m, 8H, Ar–H), 7.91 (d, 2H, J= 7.9 Hz, C3-H & C5-H pyr-
idine ring), 8.19 (s, 1H, –SO2–NH–), 8.90 (d, 2H, pyrimidine),
8.99 (d, 2H, J= 8.1 Hz, C2-H & C6-H pyridine ring), 9.92 (s,
1H, –NH–CO–), 11.01 (s, 1H, –COOH); 13C NMR
(100 MHz, DMSO-d6, d, ppm): 164.1 (1C, C–NH– attached
with arylsulfonamide group), 164.8 (1C, C‚O), 168.5 (1C,
C–NH–Ar), 169.2 (1C, C–NHSO2–), 169.8 (1C, –COOH),
176.6 (1C, C–NHNHCO– triazine ring); LC–MS (m/z):
599.14 (M+), Anal. Calcd. For: C26H21N11O5S, C – 52.08,
H – 3.53, N – 25.70; Found: C – 52.14, H – 3.61, N –
25.78%.
2.4.22. Physical constants and characterization of ethyl-4-(4-(2-
isonicotinoylhydrazinyl)-6-(4-(N-pyrimidin-2-
ylsulfamoyl)phenylamino)-1,3,5-triazin-2-ylamino)benzoate
(3v)
Yield: 66.0%, m.p. 288 C; IR (KBr, m, cm1): 742 (C–H,
bending in aromatic), 928 (S–N, stretching), 1146 (S‚O,
stretching in SO2), 1248 (C–O, stretching, ester), 1633 (N–H,
bending), 1643 (C‚C, stretching), 1742 (C‚O, stretching in
ester), 1856 (C‚N, stretching), 2885 (C–H, stretching in
–CH3), 3092 (C–H, stretching in aromatic ring), 3442 (N–H,
stretching in amine); 1H NMR (300 MHz, DMSO-d6, d,
ppm): 1.30 (t, 3H, –COOCH2CH3), 4.30 (q, 2H,
–COOCH2CH3), 6.65 (s, 2H, Ar–NH–triazine), 6.86 (s, 1H,
triazine–NH–NH–), 6.95 (t, 1H, pyrimidine), 7.08–7.71 (m,
8H, Ar–H), 7.86 (d, 2H, J= 7.8 Hz, C3-H & C5-H pyridine
ring), 8.12 (s, 1H, –SO2–NH–), 8.87 (d, 2H, pyrimidine), 8.98
(d, 2H, J= 7.9 Hz, C2-H & C6-H pyridine ring), 9.91 (s, 1H,
–NH–CO–); 13C NMR (100 MHz, DMSO-d6, d, ppm): 14.4
(1C, –COOCH2CH3), 60.7 (1C, –COOCH2CH3), 164.3 (1C,
C–NH– attached with arylsulfonamide group), 164.8 (1C,
C‚O), 165.7 (1C, –COOCH2CH3), 168.6 (1C, C–NH–Ar),
169.2 (1C, C–NHSO2–), 176.3 (1C, C–NHNHCO– triazine
ring); LC–MS (m/z): 627.18 (M+), Anal. Calcd. For:
C28H25N11O5S, C – 53.58, H – 4.01, N – 24.55; Found:
C – 53.57, H – 4.05, N – 24.54%.
Synthesis of benzenesulfonamide derivatives S312.5. Antibacterial assay
The synthesized compounds were screened for their antibacte-
rial activity against Gram Positive bacteria [Staphylococcus
aureus (MTCC-96), Staphylococcus pyogenes (MTCC-442)]
and Gram-negative bacteria [Escherichia coli (MTCC-443),
Pseudomonas aeruginosa (MTCC-1688)]. The antibacterial
activity was carried out by preparing serial dilution of given
solution using the Mueller Hinton Broth dilution method (Bec-
ton Dickinson, USA) [9,6,7]. The standard strains used for
antimicrobial activity were procured from the Institute of
Microbial Technology, Chandigarh. The compounds (3a–v)
were screened for their antibacterial activity in triplicate sets
against these bacteria at different concentrations of 1000,
500, 250, and 200 lg/mL. The drugs which were found to be
active in primary screening were further diluted to obtain
100, 50, and 25 lg/mL concentrations. Ten lg/mL suspensions
were further inoculated on appropriate media and growth was
noted after 24 and 48 h. The lowest concentration, which
showed no growth after spot subculture was considered as
MIC for each drug. The highest dilution showing at least
99% inhibition was taken as minimum inhibitory concentra-
tion (MIC). The test mixture should contain 108 cells/mL.
The standard drug used in this study was ampicillin for evalu-
ating antibacterial activity which showed (100, 100, 250, and
100 lg/mL) MIC against E. coli, P. aeruginosa, S. aureus,
and S. pyogenes, respectively.
2.6. Antifungal assay
Similarly, various concentrations of compounds (3a–v) were
tested for antifungal activity in triplicate sets against Candida
albicans, Aspergillus niger and Aspergillus clavatus at various
concentrations of 1000, 500, 250, 200, and 100 lg/mL and
the obtained results were recorded in the form of primary
and secondary screening. The synthesized compounds were
prepared as stock solution diluted to 1000 lg/mL concentra-0-5ºC, NaOH
Acetone, 2h
N
1,4-D
Ref lux,
H2N
NaOH,
(3a-v)
Where,R=
-H, -4-Br, -2-Cl, -3-Cl, -4-Cl, -2,5-(Cl)2, -2,6-(Cl)2, -4F
-4-CF3, -4-OCH3, -2,4-(OCH3)2, -4-OC2H5, -2-NO2, -3
N C
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Scheme 1 Synthetic route fotion. The compounds which were found to be active in this pri-
mary screening were further tested in a second set of dilution
against all microorganisms. The lowest concentration, which
showed no growth after spot subculture was considered as
MIC for each drug. The highest dilution showing at least
99% inhibition was taken as MIC. The test mixture should
contain 108 spores/mL MIC. Griseofulvin was used as a stan-
dard drug for antifungal activity, which showed (500, 100, and
100 lg/mL) MIC against C. albicans and A. niger, respectively.
3. Results and discussion
3.1. Chemistry
The synthetic route for intermediates and ﬁnal compounds
(3a–v) is shown in the reaction (Scheme 1). The present scaf-
fold (3a) is a part of the synthesis of new chemical entities in
the form of antimicrobial agents. The starting material 1,3,5-
trichlorotriazine was reacted with isoniazid (i.e., ison-
icotinohydrazide) and the intermediate compound N0-(4,6-di-
chloro-1,3,5-triazine-2-yl)isonicotinohydrazide (1) was
obtained in good yield. Compound (1) was stirred for 3 h with
4-amino-N-(pyrimidin-2-yl)benzenesulfonamide in acetone.
Then the reaction mixture was treated with dil. HCl to form
compound (4-(4-chloro-6-(2-isonicotinoylhydrazinyl)-1,3,5-
triazin-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamide (2).
Compound (2) was then reﬂuxed in 1,4-dioxane with different
aromatic amines to furnish ﬁnal compounds (3a–v). Character-
ization of the newly synthesized compounds was accomplished
by different spectral techniques. IR spectra of the synthesized
compound (3a) (molecular formula C25H21N11O3S, m. wt.
555.15 g/mol) showed different types of absorption bands in
the spectrum, i.e., N–H stretching in amide link showed strong
absorption band at 3448 cm1 whereas N–H stretching in thi-
oamide linkage exhibited vibrational intensity band at
3471 cm1. In addition, N–H attached with the triazine and
aryl group showed absorption at 3388 cm1, while N–H linkedH2N S
O
O
N
N
N
C
O
N
N
N
ClN
C
O
NH
NH
ioxane
Acetone
R
H
NH S
O
NH
N
N
, -2-CH3, -4-CH3, -2,4-(CH3)2, -2,6-(CH3)2, -3-CF3,
-NO2, -4-NO2, -4-COOHand -4-COOC2H5
O
(1)
(2)
NH
NH
N
N
N
Cl
Cl
RT, 3hNaOH
+
h
r ﬁnal compounds (3a–v).
S32 N.C. Desai et al.with the triazine ring and –NHCO appeared at 3412 cm1.
Medium intensity absorption band was exhibited at
3038 cm1 due to C–H stretching in the pyridine ring and it
closely resembled monosubstituted benzene derivatives, while
C–H stretching in the aromatic ring appeared at 3020 cm1.
The stretching bands appearing over the range 1640 and
1890 cm1 showed the presence of C‚C and C‚N stretching
in pyridine, pyrimidine and phenyl rings respectively. Strong
intensity absorption peak at 795 cm1 showed C–H bending
vibration in the aromatic ring. Medium intensity band ap-
peared at 895 cm1 due to the presence of S–N stretching in
compound (3a). Strong IR band appearing at 1690 cm1
showed C‚O stretching and the medium intensity absorption
peak observed at 1120 cm1 exhibited the presence of S‚O
stretching in SO2.
In 1H NMR spectra of the titled compound (3a), ﬁve sing-
lets were observed for ﬁve protons of –NH i.e., a –NH proton
attached with triazine and –NHCO appeared at d= 6.82 ppm,
two –NH protons attached with the triazine and aryl group
exhibited signal at d= 6.64 ppm, a –NH proton in sulfon-
amide linkage showed chemical shift at d= 8.13 ppm and –
NH attached with the carbonyl group displayed chemical shift
at d= 9.78 ppm. Due to the presence of nine aromatic protons
(Ar–H) a multiplet was observed at d= 6.93–7.65 ppm. A
chemical shift was observed at d= 6.98–8.89 ppm due to the
presence of seven multiplet (Ar–H) in the pyridine and pyrim-
idine rings of the titled compound. The ﬁnal compound (3a)
possessed three moieties pyridine, pyrimidine and 1,3,5-tri-
azine. On the basis of 13C NMR of the ﬁnal compound (3a),
the chemical shift varied from d= 113.0 to 176.5 ppm. Carbon
nucleus under the inﬂuence of strong electronegative environ-Table 1 Results of antibacterial and antifungal activities of compo
Sr. No. –R Minimum inhibitory concentration (MIC) in l
E. coli
MTCC 443
P. aeruginosa
MTCC 1688
S. aureus
MTCC 96
S.
M
3a –H 100 100 250 10
3b –4-Br 100 200 100 10
3c –2-Cl 100 250 100 10
3d –3-Cl 250 100 250 25
3e –4-Cl 250 100 100 50
3f –2,5-(Cl)2 100 500 500 25
3g –2,6-(Cl)2 50 250 500 25
3h –4-F 50 500 250 10
3i –2-CH3 100 500 250 50
3j –4-CH3 250 500 500 25
3k –2,4-(CH3)2 100 250 250 50
3l –2,6-(CH3)2 250 100 100 50
3m –3-CF3 200 500 250 50
3n –4-CF3 100 250 100 50
3o –4-OCH3 250 500 500 25
3p –2,4-(OCH3)2 100 500 500 50
3q –4-OC2H5 200 250 500 50
3r –2-NO2 100 100 500 50
3s –3-NO2 100 100 250 25
3t –4-NO2 50 100 50 10
3u –4-COOH 250 500 100 10
3v –4-COOC2H5 50 500 50 50
Ampicillin 100 100 250 10
Griseofulvin – – – –ment appeared downﬁeld i.e., carbonyl carbon present in
amide linkage directly attached to nitrogen exhibited chemical
shift value at d= 164.4 ppm. Carbon present in the pyrimidine
nucleus directly linked to nitrogen atoms appeared downﬁeld
at d= 169.3 ppm. Three carbons of triazine nucleus displayed
chemical shift value at d= 164.1, 168.9 and 176.7 ppm corre-
sponding to carbons attached with the phenyl sulfonamide
group, aniline and –NH of the hydrazide group, respectively.
3.2. Antimicrobial activity
Many of the newly synthesized compounds were found to ex-
hibit good to excellent antimicrobial activity. The individual
minimum inhibitory concentration (MIC, lg/mL) values of
tested compounds (3a–v) against the test microbes are listed
in Table 1 along with MIC values of reference compounds
ampicillin (for bacteria) and griseofulvin (for fungi). The re-
sults revealed that majority of synthesized compounds showed
varying degrees of inhibition against the tested panel of spe-
cies. The obtained antimicrobial activity of tested compounds
could be correlated to structural variations and modiﬁcations
of the respective compounds. From antimicrobial activity data
(Table 1), it is observed that compounds 3a (–H), 3b (–4-Br),
3c (–2-Cl), 3f (–2,5-(Cl)2), 3i (–2-CH3), 3k (–2,4-(CH3)2), 3n
(–4-CF3), 3p (–2,4-(OCH3)2, 3r (–2-NO2) and 3s (–3-NO2) pos-
sessed good activity against E. coli at MIC 100 lg/mL.
Compounds 3g (–2,6-(Cl)2), 3h (–4-F), 3t (–4-NO2) and 3v
(–4-COOC2H5) showed excellent activity against E. coli
at MIC 50 lg/mL, respectively. Compounds 3a (–H), 3d
(–3-Cl), 3e (–4-F), 3l (–2,6-(CH3)2), 3r (–2-NO2), 3s (–3-NO2)
and 3t (–4-NO2) exhibited very good activity againstunds 3a–v.
g/mL Minimum inhibitory concentration (MIC) in lg/mL
pyogenes
TCC 442
C. albicans
MTCC 227
A. niger
MTCC 282
A. clavatus
MTCC 1323
0 1000 >1000 >1000
0 500 >1000 >1000
0 500 >1000 >1000
0 250 >1000 >1000
0 1000 1000 1000
0 100 250 500
0 50 100 500
00 50 250 500
0 250 500 1000
0 500 500 1000
0 250 500 1000
0 1000 >1000 >1000
0 100 >1000 >1000
0 100 1000 1000
0 500 1000 500
0 1000 200 500
0 500 500 1000
0 500 1000 >1000
0 250 500 1000
0 >1000 >1000 >1000
0 500 1000 >1000
0 >1000 >1000 >1000
0 – – –
500 100 100
Synthesis of benzenesulfonamide derivatives S33P. aeruginosa at MIC 100 lg/mL. Compounds 3b (–4-Br), 3c
(–2-Cl), 3e (–4-F), 3l (–2,6-(CH3)2), 3n (–4-CF3) and 3u
(–4-COOH) possessed very good activity against S. aureus at
MIC 100 lg/mL, while compounds 3t (–4-NO2) and 3v
(–4-COOC2H5) ﬂaunted excellent activity against S. aureus at
MIC 50 lg/mL. Compounds 3a (–H), 3b (–4-Br), 3C (–2-Cl),
3t (–4-NO2) and 3u (–COOH) exhibited very good activity
against S. pyogenes at MIC 100 lg/mL. Among all the synthe-
sized compounds, 3f (–2,5-(Cl)2), 3m (–3-CF3) and 3n (–4-CF3)
possessed very good activity against C. albicans at MIC
100 lg/mL. Compounds 3g (–2,6-(Cl)2 and 3h (–4-F) showed
excellent activity against C. albicans at MIC 50 lg/mL.
4. Structure–activity relationship (SAR)
The substitution pattern of s-triazine derivatives was carefully
selected to confer different electronic environment to mole-
cules. The results from antimicrobial activity suggested that
s-triazine derivatives were remarkably inﬂuenced by various
substituents on the benzene ring. Majority of the synthesized
compounds of this series exhibited signiﬁcant antibacterial
and moderate antifungal activity. Compounds 3g, 3h, 3t and
3v exhibited highest inhibition against bacterial strains
S. aureus and E. coli at MIC 50 lg/mL. Furthermore,
compounds 3g and 3h showed signiﬁcant inhibition against
fungi strains C. albicans at MIC 50 lg/mL. The data revealed
that incorporation of electron withdrawing groups like halo-
gen, nitro and ester on the phenyl ring enhanced antimicrobial
activity against selected microorganisms. Thus, our aim was to
explore SAR trends and to ﬁnd out lead molecule for further
optimization.
5. Conclusions
A series of twenty-two s-triazine derivatives were synthesized
and tested for their in vitro antibacterial activity against four
strains of bacteria (Gram-positive, Gram-negative). The pre-
liminary in vitro antibacterial and antifungal screening results
of new 1,3,5-triazine-isonicotinohydrazide derivatives exhib-
ited remarkable antimicrobial potency. The newly synthe-
sized compounds differed in their corresponding
antimicrobial activity depending on the type of substituents
on the phenyl ring. Presence of the electron withdrawing
group on the aromatic ring increased the antimicrobial activ-
ity compared to compounds with electron donating groups.
Based on the results, we can further optimize the above com-
pounds by substituting a series of electron withdrawing
groups on the aromatic ring and selectively modifying them.
Thus, it may be considered a promising lead for further design
and development of new chemical entities. The results de-
scribed here, demand further investigations in our laboratory
using a forward chemical genetic approach for ﬁnding lead
molecules as antimicrobial agents.Acknowledgements
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